Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential

E. Milia, M. Usai, B. Szotáková, M. Elstnerová, V. Králová, G. D'hallewin, Y. Spissu, A. Barberis, M. Marchetti, A. Bortone, V. Campanella, G. Mastandrea, L. Langhansová, S. Eick,

. 2020 ; 9 (6) : . [pub] 20200526

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20019138

BACKGROUND: Given the increasing request for natural pharmacological molecules, this study assessed the antimicrobial capacity of Pistacia lentiscus L. essential oil (PLL-EO) obtained from the leaves of wild plants growing in North Sardinia (Italy) toward a wide range of periodontal bacteria and Candida, including laboratory and clinical isolates sp., together with its anti-inflammatory activity and safety. METHODS: PLL-EO was screened by gas chromatography/mass spectrometry. The minimal inhibitory concentration (MIC) was determined. The anti-inflammatory activity was measured by cyclooxygenase (COX-1/2) and lipoxygenase (LOX) inhibition, while the antioxidant capacity was determined electro-chemically and by the MTT assay. The WST-1 assay was used to ascertain cytotoxicity toward four lines of oral cells. RESULTS: According to the concentrations of terpens, PLL-EO is a pharmacologically-active phytocomplex. MICs against periodontal bacteria ranged between 3.13 and 12.5 µg/ml, while against Candida sp. they were between 6.25 and 12.5 µg/mL. Oxidation by COX-1/2 and LOX was inhibited by 80% and 20% µg/mL of the oil, respectively. Antioxidant activity seemed negligible, and no cytotoxicity arose. CONCLUSIONS: PLL-EO exhibits a broad-spectrum activity against periodontal bacteria and Candida, with an interesting dual inhibitory capacity toward COX-2 and LOX inflammatory enzymes, and without side effects against oral cells.

000      
00000naa a2200000 a 4500
001      
bmc20019138
003      
CZ-PrNML
005      
20201123124054.0
007      
ta
008      
201103s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antibiotics9060281 $2 doi
035    __
$a (PubMed)32466371
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Milia, Egle $u Surgery and Experimental Science, Department of Medicine, University of Sassari, Viale San Pietro 43, 07100 Sassari, Italy.
245    14
$a The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential / $c E. Milia, M. Usai, B. Szotáková, M. Elstnerová, V. Králová, G. D'hallewin, Y. Spissu, A. Barberis, M. Marchetti, A. Bortone, V. Campanella, G. Mastandrea, L. Langhansová, S. Eick,
520    9_
$a BACKGROUND: Given the increasing request for natural pharmacological molecules, this study assessed the antimicrobial capacity of Pistacia lentiscus L. essential oil (PLL-EO) obtained from the leaves of wild plants growing in North Sardinia (Italy) toward a wide range of periodontal bacteria and Candida, including laboratory and clinical isolates sp., together with its anti-inflammatory activity and safety. METHODS: PLL-EO was screened by gas chromatography/mass spectrometry. The minimal inhibitory concentration (MIC) was determined. The anti-inflammatory activity was measured by cyclooxygenase (COX-1/2) and lipoxygenase (LOX) inhibition, while the antioxidant capacity was determined electro-chemically and by the MTT assay. The WST-1 assay was used to ascertain cytotoxicity toward four lines of oral cells. RESULTS: According to the concentrations of terpens, PLL-EO is a pharmacologically-active phytocomplex. MICs against periodontal bacteria ranged between 3.13 and 12.5 µg/ml, while against Candida sp. they were between 6.25 and 12.5 µg/mL. Oxidation by COX-1/2 and LOX was inhibited by 80% and 20% µg/mL of the oil, respectively. Antioxidant activity seemed negligible, and no cytotoxicity arose. CONCLUSIONS: PLL-EO exhibits a broad-spectrum activity against periodontal bacteria and Candida, with an interesting dual inhibitory capacity toward COX-2 and LOX inflammatory enzymes, and without side effects against oral cells.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Usai, Marianna $u Department of Chemistry and Pharmacy, University of Sassari, Via Rolando, 07100 Sassari, Italy.
700    1_
$a Szotáková, Barbora $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
700    1_
$a Elstnerová, Marie $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
700    1_
$a Králová, Věra $u Faculty of Medicine, Charles University, Šimkova 870, 50003 Hradec Králové, Czech Republic.
700    1_
$a D'hallewin, Guy $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
700    1_
$a Spissu, Ylenia $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
700    1_
$a Barberis, Antonio $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
700    1_
$a Marchetti, Mauro $u National Research Council - Institute of Biomolecular Chemistry, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
700    1_
$a Bortone, Antonella $u Dental Unite, Department of Surgery, Azienda Ospedaliero Universitaria, 07100 Sassari, Italy.
700    1_
$a Campanella, Vincenzo $u Department of Clinical and Translational Medicine, University of Rome, Tor Vergata, 00133 Rome, Italy.
700    1_
$a Mastandrea, Giorgio $u Department of Biomedical Science, University of Sassari, Viale San Pietro 43/C, 07100 Sassari, Italy.
700    1_
$a Langhansová, Lenka $u Institute of Experimental Botany, Czech Academy of Sciences, Rozvojová 263, 16502 Prague, Czech Republic.
700    1_
$a Eick, Sigrun $u Department of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, 3010 Bern, Switzerland.
773    0_
$w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 9, č. 6 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32466371 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201103 $b ABA008
991    __
$a 20201123124053 $b ABA008
999    __
$a ind $b bmc $g 1585918 $s 1109336
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 6 $e 20200526 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
LZP    __
$a Pubmed-20201103

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...